跳至主要内容
临床试验/NCT03073304
NCT03073304已完成不适用

A Randomized Controlled Study With the Aim to Compare Crystalloid Prime Solution With a Prime Solution Containing Packed Red Blood Cells in Relation to the Patient's Regional Metabolic Needs and Immunological Influence During Isolated Limb Perfusion

Vastra Gotaland Region1 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2017年2月24日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
18
试验地点
1
主要终点
Lactate level during and after perfusion.

研究概览

简要总结

The primary aim of this study is to investigate the possibility to replace an erythrocyte based prime solution with a crystalloid based prime solution while maintaining metabolic function. Secondary also to study if potentially reduced immunological influence is obtained during hyper thermic isolated limb perfusion with a crystalloid based prime solution.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •The patient scheduled for treatment with isolated hyperthermic perfusion
  • •Age over 18 years.
  • •Signed informed consent

排除标准

  • 未提供

研究组 & 干预措施

Control

Active Comparator

Erythrocyte based prime solution

干预措施: Erythrocyte based prime solution (Drug)

Intervention

Experimental

Crystalloid based prime solution

干预措施: Crystalloid based prime solution (Drug)

结局指标

主要结局

Lactate level during and after perfusion.

时间窗: 1 hour

Lactate level during and after perfusion.

次要结局

  • Complications(30 days)
  • Oxygen extraction during, and after perfusion.(1 hour)
  • Arterial oxygen and regional venous oxygen saturation during and after completion of perfusion.(1 hour)
  • Hematocrit during and after completion of perfusion.(1 hour)
  • Immunological effects(30 days)

研究者

发起方
Vastra Gotaland Region
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Roger Olofsson Bagge

Associate professor

Sahlgrenska University Hospital, Sweden

研究点 (1)

Loading locations...

相似试验